These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23977238)

  • 1. In vivo delivery of adenoviral vector containing interleukin-17 receptor a reduces cardiac remodeling and improves myocardial function in viral myocarditis leading to dilated cardiomyopathy.
    Xie Y; Li M; Wang X; Zhang X; Peng T; Yang Y; Zou Y; Ge J; Chen H; Chen R
    PLoS One; 2013; 8(8):e72158. PubMed ID: 23977238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis.
    Guo Y; Wu W; Cen Z; Li X; Kong Q; Zhou Q
    Virol J; 2014 Dec; 11():230. PubMed ID: 25547181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated ICOSIg gene transfer alleviates cardiac remodeling in experimental autoimmune myocarditis.
    Liu W; Feng W; Wang F; Li W; Zhou B; Gao C; Li Y; Kong Y; Ma M; Fu S
    Immunol Cell Biol; 2008; 86(8):659-65. PubMed ID: 19005474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic trypsin in the myocardium promotes dilated cardiomyopathy after influenza A virus infection.
    Pan HY; Sun HM; Xue LJ; Pan M; Wang YP; Kido H; Zhu JH
    Am J Physiol Heart Circ Physiol; 2014 Sep; 307(6):H922-32. PubMed ID: 25038143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
    Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
    Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
    Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
    Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy.
    Baldeviano GC; Barin JG; Talor MV; Srinivasan S; Bedja D; Zheng D; Gabrielson K; Iwakura Y; Rose NR; Cihakova D
    Circ Res; 2010 May; 106(10):1646-55. PubMed ID: 20378858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of interleukin-17A protects against coxsackievirus B3-induced myocarditis by increasing COX-2/PGE2 production in the heart.
    Xie Y; Chen R; Zhang X; Yu Y; Yang Y; Zou Y; Ge J; Chen H; Garzino-Demo A
    FEMS Immunol Med Microbiol; 2012 Apr; 64(3):343-51. PubMed ID: 22141571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy.
    Chen P; Xie Y; Shen E; Li GG; Yu Y; Zhang CB; Yang Y; Zou Y; Ge J; Chen R; Chen H
    Eur J Pharmacol; 2011 May; 658(2-3):168-74. PubMed ID: 21371462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
    Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
    Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-37 Ameliorates Coxsackievirus B3-induced Viral Myocarditis by Modulating the Th17/Regulatory T cell Immune Response.
    An B; Liu X; Li G; Yuan H
    J Cardiovasc Pharmacol; 2017 May; 69(5):305-313. PubMed ID: 28207428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n.
    Coronado MJ; Brandt JE; Kim E; Bucek A; Bedja D; Abston ED; Shin J; Gabrielson KL; Mitzner W; Fairweather D
    Am J Physiol Heart Circ Physiol; 2012 Apr; 302(8):H1726-36. PubMed ID: 22328081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease.
    Liu W; Feng W; Wang F; Li W; Gao C; Zhou B; Ma M
    Exp Mol Pathol; 2008 Jun; 84(3):213-7. PubMed ID: 18417124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice.
    Huber SA; Feldman AM; Sartini D
    Circ Res; 2006 Nov; 99(10):1109-16. PubMed ID: 17038643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling.
    Gui J; Yue Y; Chen R; Xu W; Xiong S
    PLoS One; 2012; 7(9):e46515. PubMed ID: 23029542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of olmesartan, an angiotensin II receptor type 1 antagonist, in rats with dilated cardiomyopathy.
    Sukumaran V; Watanabe K; Veeraveedu PT; Thandavarayan RA; Gurusamy N; Ma M; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
    Exp Biol Med (Maywood); 2010 Nov; 235(11):1338-46. PubMed ID: 20876084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up-regulating matrix metalloproteinase 9 expression in mice.
    Jenke A; Schur R; Röger C; Karadeniz Z; Grüger M; Holzhauser L; Savvatis K; Poller W; Schultheiss HP; Landmesser U; Skurk C
    Physiol Rep; 2017 Dec; 5(24):. PubMed ID: 29263115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stromal Cells Modulate Monocytes Trafficking in Coxsackievirus B3-Induced Myocarditis.
    Miteva K; Pappritz K; El-Shafeey M; Dong F; Ringe J; Tschöpe C; Van Linthout S
    Stem Cells Transl Med; 2017 Apr; 6(4):1249-1261. PubMed ID: 28186704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protective effect and mechanism of IL-17 monoclonal antibody on mice with viral myocarditis].
    Qian H; Liu L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):509-12. PubMed ID: 24796747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17 contributes to cardiac fibrosis following experimental autoimmune myocarditis by a PKCβ/Erk1/2/NF-κB-dependent signaling pathway.
    Liu Y; Zhu H; Su Z; Sun C; Yin J; Yuan H; Sandoghchian S; Jiao Z; Wang S; Xu H
    Int Immunol; 2012 Oct; 24(10):605-12. PubMed ID: 22531062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.